medline.ch Neurologie Multiple Sklerose

	The economic impact, healthcare resource utilization, and clinical outcome over 24â€‰months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- the fidelity study. Expert Rev Pharmacoecon Outcomes Res Kourlaba G, Koutsis G, Fakas N, Tsimourtou V, Karachalios G, Bakirtzis C, Girgoriadis N. PMID: 41390331 [PubMed - as supplied by publisher]
	Experiences of people with multiple sclerosis using clean Ä±ntermittent catheterization: a qualitative study. Disabil Rehabil Polat Dunya C, Özkan , Yalç, Gunduz T, Kurtuncu M. PMID: 41390241 [PubMed - as supplied by publisher]
	Multiple sclerosis research in 2025: earlier diagnosis and halting progression. Lancet Neurol Pittock SJ. PMID: 41389817 [PubMed - in process]
	A Scoping Review of Transition to Adult Care in Pediatric-Onset Multiple Sclerosis: An Opportunity to Advance Research. Pediatr Neurol Gambrah-Lyles C, Barter K, Doering M, Mar S. PMID: 41389765 [PubMed - as supplied by publisher]
	Blood neurofilament light chain in patients with multiple sclerosis: A systematic review and updated meta-analysis. Exp Gerontol Ebrahimi R, Seifi M, Masouri MM, Ravari Nejad M, Azad G, Kabiri AH, Noori S. PMID: 41389596 [PubMed - as supplied by publisher]
	Ramadan fasting in multiple sclerosis: A systematic review. Mult Scler Relat Disord Nourmohammad A, Zorriyeh-Sheikhali M, Sanaie S, Naseri A. PMID: 41389459 [PubMed - as supplied by publisher]
	The revised 2024 McDonald diagnostic criteria can solve the misdiagnosis problem in multiple sclerosis: NO. Mult Scler Gomez-Figueroa E, Casallas-Vanegas A. PMID: 41388898 [PubMed - as supplied by publisher]
	Proteome-Wide Mendelian Randomization Implicates Shared Necroptosis-Ferroptosis Effectors in Causal Pathways of Multiple Sclerosis Susceptibility. Ann N Y Acad Sci Yan W, Jianhong W, Wen J, Linming Z. PMID: 41387240 [PubMed - as supplied by publisher]
	Influence of FCGR2A (rs1801274) and FCGR3A (rs396991) polymorphisms on natalizumab response on multiple sclerosis. Mult Scler Relat Disord Cardoso RC, de Matos MD, Duarte LA, Guimenes BD, Pavani GK, Gutman EG, Ferreira HFA, Pereira VCSR, Domingues VB, Farinhas JGD, Fernandez KA, Schmidt FR, Montes GC, Alves-Leon SV, Fontes-Dantas FL. PMID: 41385984 [PubMed - as supplied by publisher]
	Onabotulinumtoxin intra-detrusor injection for lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Caspian J Intern Med Soltanzadi A, Mirmosayyeb O, Momeni Moghaddam A, Vaheb S, Ghajarzadeh M. PMID: 41383791 [PubMed]
	Redefining Multiple Sclerosis with CAR-T Cell Therapy. Mol Ther Li YR, Chen Y, Yang L. PMID: 41383015 [PubMed - as supplied by publisher]
	Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region. Mult Scler Relat Disord Kim HJ, Hodgkinson SJ, Ro LS, Situmeang RFV, Siritho S, Tan K, Nghia HTT, Viswanathan S, Alexander LYL, Loke H, Tay RJ, Taha K, Zeineddine M, Yamout B. PMID: 41380511 [PubMed - as supplied by publisher]
	The impact of COVID-19 on medical care and health service access in persons with multiple sclerosis - a cross-sectional study from the Australian MS Longitudinal Study. Mult Scler Relat Disord Tan J, Marck CH, Galna B, Laslett LL, van der Mei I, Learmonth YC. PMID: 41380510 [PubMed - as supplied by publisher]
	Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis. Mult Scler Relat Disord Hauser SL, Freedman MS, Nakahara J, Paling D, de Seze J, Li J, Abeyewickreme A, Wu M, Sullivan R, Pardo G, Montalban X, Wiendl H. PMID: 41380509 [PubMed - as supplied by publisher]
	Towards practical management of the Marburg variant of multiple sclerosis. Mult Scler Relat Disord Sredanovi, Bunoza B, Lehman I, Jurin M, Nenadi, Plosni, Gr, Weiss M, Jovanovi, Brnadi, Te, Bili, Turudi, Krbot Skori, Habek M. PMID: 41380461 [PubMed - as supplied by publisher]
	The association between objective measures of sleep and physical activity in individuals with multiple sclerosis. Mult Scler Relat Disord Einav-Farber A, Menascu S, Drori T, Kalron A. PMID: 41380459 [PubMed - as supplied by publisher]
	Simulation of Clinical Visits as a Novel Approach to Evaluate Digital Health in Multiple Sclerosis: Simulation Study. JMIR Med Inform Bove R, Capezzuto L, West I, Dryden S, Ghafur S, Halligan J, Hubeaux S, Kazlauskaite A. PMID: 41380024 [PubMed - indexed for MEDLINE]
	Real-world data on switches of the employment status in people with multiple sclerosis: a longitudinal observational study of the German MS Register. Neuroepidemiology Peters M, Eichstädt K, Stahmann A, Kirstein M, Blohm U, Flachenecker P, Schumann N, Frahm N. PMID: 41379765 [PubMed - as supplied by publisher]
	Feasibility and Preliminary Effects of Ballet-Based Group Dance Intervention in Relapsing-Remitting Multiple Sclerosis: A Pilot Study. J Clin Med Ivaldi D, Lombardo R, Triolo G, Restuccia G, Susinna C, Bonanno L, Rifici C, D'Aleo G, Sessa E, Quartarone A, Lo Buono V. PMID: 41375914 [PubMed]
	The Potential of Î²-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis. Int J Mol Sci Osmond GE, John NA, Ting YT, Ooi JD. PMID: 41373685 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 42897

Seite 1 von 2145

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung